Article
Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers.
Cancer gene therapy - 1 Dec 2002
Zeh Herbert J, Bartlett David L
Abstract excerpt
Tumor directed gene therapy for the purpose of destroying cancer cells through replicative "oncolysis" or by intratumoral expression of toxic or immunostimulatory genes requires an efficient, tumor targeted vector. Vectors are limited by inefficient replication in vivo, inefficient tumor targeting, and safety concerns. As a unique approach to addressing these limitations, our laboratory has studied poxviruses as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
